MCID: GLL012
MIFTS: 22

Gallbladder Melanoma malady

Categories: Cancer diseases, Gastrointestinal diseases, Skin diseases

Aliases & Classifications for Gallbladder Melanoma

Aliases & Descriptions for Gallbladder Melanoma:

Name: Gallbladder Melanoma 12 14 69
Malignant Melanoma of Gallbladder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8167
NCIt 47 C5735
UMLS 69 C1333749

Summaries for Gallbladder Melanoma

MalaCards based summary : Gallbladder Melanoma, also known as malignant melanoma of gallbladder, is related to hashimoto's encephalitis and demyelinating disease. An important gene associated with Gallbladder Melanoma is PMEL (Premelanosome Protein). The drugs Fentanyl and Methylphenidate have been mentioned in the context of this disorder. Related phenotypes are integument and no phenotypic analysis

Related Diseases for Gallbladder Melanoma

Graphical network of the top 20 diseases related to Gallbladder Melanoma:



Diseases related to Gallbladder Melanoma

Symptoms & Phenotypes for Gallbladder Melanoma

MGI Mouse Phenotypes related to Gallbladder Melanoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 integument MP:0010771 9.33 MITF MLANA PMEL
2 no phenotypic analysis MP:0003012 9.13 MITF MLANA PMEL
3 pigmentation MP:0001186 8.8 MITF MLANA PMEL

Drugs & Therapeutics for Gallbladder Melanoma

Drugs for Gallbladder Melanoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 54)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
3
Morphine Approved, Investigational Phase 3 57-27-2 5288826
4 Liver Extracts Phase 3,Phase 2,Phase 1
5 Adjuvants, Anesthesia Phase 3
6 Analgesics Phase 3
7 Analgesics, Opioid Phase 3
8 Anesthetics Phase 3
9 Anesthetics, General Phase 3
10 Anesthetics, Intravenous Phase 3
11 Central Nervous System Depressants Phase 3
12 Narcotics Phase 3
13 pancreatic polypeptide Phase 3,Phase 2
14 Peripheral Nervous System Agents Phase 3
15 Epoetin alfa Phase 3 113427-24-0
16 Cola Nutraceutical Phase 3,Phase 2,Phase 1
17
Melphalan Approved Phase 2 148-82-3 4053 460612
18
Pancrelipase Approved Phase 2 53608-75-6
19 Alkylating Agents Phase 2,Phase 1
20 Antineoplastic Agents, Alkylating Phase 2,Phase 1
21 Immunosuppressive Agents Phase 2,Phase 1
22 pancreatin Phase 2
23
Carboplatin Approved Phase 1 41575-94-4 10339178 498142 38904
24
Cisplatin Approved Phase 1 15663-27-1 84093 441203 2767
25
Cyclophosphamide Approved, Investigational Phase 1 50-18-0, 6055-19-2 2907
26
Etoposide Approved Phase 1 33419-42-0 36462
27
Ifosfamide Approved Phase 1 3778-73-2 3690
28
Lenograstim Approved Phase 1 135968-09-1
29
Mechlorethamine Approved Phase 1 51-75-2 4033
30
Mesna Approved Phase 1 3375-50-6 598
31
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
32
Docetaxel Approved May 1996, Investigational Phase 1 114977-28-5 148124 9877265
33 Interferon-beta Phase 1
34 interferons Phase 1
35 Vaccines Phase 1
36
Entinostat Phase 1
37 Histone Deacetylase Inhibitors Phase 1
38 Angiogenesis Inhibitors Phase 1
39 Angiogenesis Modulating Agents Phase 1
40 Anti-Bacterial Agents Phase 1
41 Anti-Infective Agents Phase 1
42 Antimitotic Agents Phase 1
43 Albumin-Bound Paclitaxel Phase 1
44 Antineoplastic Agents, Phytogenic Phase 1
45 Antirheumatic Agents Phase 1
46 Etoposide phosphate Phase 1
47 Isophosphamide mustard Phase 1
48 Topoisomerase Inhibitors Phase 1
49
Dimenhydrinate Approved 523-87-5 441281
50
Ethanol Approved 64-17-5 702

Interventional clinical trials:

(show all 12)
id Name Status NCT ID Phase
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
2 E-MOSAIC Electronic Tool to Monitor Symptoms Completed NCT00477919 Phase 3
3 Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer Completed NCT00096083 Phase 2
4 Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Unknown status NCT00066404 Phase 1
5 Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Completed NCT00423254 Phase 1
6 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1
7 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1
8 High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer Completed NCT00002854 Phase 1
9 Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery Recruiting NCT02714374 Phase 1
10 OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer Completed NCT00900302
11 Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer Recruiting NCT00588263
12 Integrated Cancer Repository for Cancer Research Recruiting NCT02012699

Search NIH Clinical Center for Gallbladder Melanoma

Genetic Tests for Gallbladder Melanoma

Anatomical Context for Gallbladder Melanoma

Publications for Gallbladder Melanoma

Articles related to Gallbladder Melanoma:

id Title Authors Year
1
Primary gallbladder melanoma in dysplastic nevus syndrome: report of case and literature review. ( 22287410 )
2011
2
Gallbladder melanoma mimicking acute acalculous cholecystitis. ( 11265063 )
2000

Variations for Gallbladder Melanoma

Expression for Gallbladder Melanoma

Search GEO for disease gene expression data for Gallbladder Melanoma.

Pathways for Gallbladder Melanoma

GO Terms for Gallbladder Melanoma

Cellular components related to Gallbladder Melanoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 melanosome GO:0042470 8.62 MLANA PMEL

Sources for Gallbladder Melanoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....